To assess the impact of sugammadex on activated partial thromboplastin time ( APTT ) and international normalized ratio for prothrombin time ( PT ( INR ) ) in healthy subjects and characterize the concentration-dependency of sugammadex effects on APTT and prothrombin time ( PT ) in normal human plasma in vitro .